| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA956: Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over |
|
Medicine details |
|
| Medicine name | etrasimod |
| Formulation | oral |
| Reference number | 4193 |
| Indication | Previously treated moderately to severely active ulcerative colitis |
| Company | Pfizer Ltd |
| BNF chapter | Gastro-intestinal system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/03/2023 |
| NICE guidance | |